The myTomorrows platform offers information and facilitates access to Clinical Trials and Expanded Access Programs available worldwide. They are dedicated to helping patients who have exhausted their regular treatment options.

myTomorrows  was created with one simple belief. Every patient should have access to all possible treatment options.

How it works

Welcome to the GRIT Study

Getting global Rare disease Insights through Technology

Join the first Canadian app-based clinical trial for patient with metabolic disorders

What does the study involve?

You will be given access to an app called Zamplo which will help you manage your condition in the following ways: be more organized, manage pain better and communicate easily.

You are eligible to participate if you are:

  • Over 18 years of age
  • Living with a diagnosis of a metabolic disorder
  • Have access to the internet

If you are interested in participating

Useful websites is a database of privately and publicly funded clinical studies conducted around the world. Click here for current trials for Fabry Disease
The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.